DOI: 10.1001/jama.2026.11892 ISSN: 0098-7484

The Psychedelic Therapies Executive Order

I. Glenn Cohen, Holly Fernandez Lynch, Amy L. McGuire

This Viewpoint discusses the executive order supporting the development and approval of psychedelic drugs and outlines issues surrounding their ethical and evidence-based integration into clinical care.

More from our Archive